| Literature DB >> 23967125 |
Andrea Egger1, Roland Kreis, Sabin Allemann, Christoph Stettler, Peter Diem, Tania Buehler, Chris Boesch, Emanuel R Christ.
Abstract
BACKGROUND: Intrahepatocellular (IHCL) and intramyocellular (IMCL) lipids are ectopic lipid stores. Aerobic exercise results in IMCL utilization in subjects over a broad range of exercise capacity. IMCL and IHCL have been related to impaired insulin action at the skeletal muscle and hepatic level, respectively. The acute effect of aerobic exercise on IHCL is unknown. Possible regulatory factors include exercise capacity, insulin sensitivity and fat availability subcutaneous and visceral fat mass). AIM: To concomitantly investigate the effect of aerobic exercise on IHCL and IMCL in healthy subjects, using Magnetic Resonance spectroscopy.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23967125 PMCID: PMC3743875 DOI: 10.1371/journal.pone.0070865
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 3Effect of aerobic exercise on intramyocellular (IMCL) and intrahepatocellular lipids (IHCL).
Individual IMCL and IHCL measurements before (pre) and after (post) a 2h-aerobic exercise at 50% VO2max of each subject. A significant decrease in IMCL (p<0.005) and a significant increase in IHCL (p<0.002) was documented. The diagram on the far right is a blow up of the IHCL data depicted in the middle part to show the changes in IHCL for volunteers with low IHCL levels. Changes (mean ± 1 SEM) of IMCL and IHCL (in % from baseline) following a 2h-aerobic exercise at 50% VO2max.
Clinical parameters, body composition and fat availability, exercise parameters, insulin sensitivity and MR-spectroscopy data in endurance trained athletes.
|
| |
| Gender | 6 F 12 M |
| Age (years) | 37.6±3.2 |
| BMI (kg/m2) | 22.5±0.6 |
| Waist | 80.4±2.2 |
|
| |
| Subcutaneous fat mass (kg) | 11.7±0.9 |
| Visceral fat mass (kg) | 1.7±0.2 |
| Basal FFA (fasting; mmol/L) | 0.280±0.032 |
| Peak FFA (during exercise; mmol/L) | 1.162±0.099 |
|
| |
| VO2max (ml/kg/min) | 53.4±2.9 |
| Workload during 2 h exercise (W) | 159.3±10.6 |
|
| |
| Suppression EGP from baseline (%; low insulin dose) | 64.6±9.07 |
| M-Value (high insulin-dose) (mg/kg/min) | 9.7±0.7 |
|
| |
| IMCL pre (mmol/kg wet weight) | 4.4±0.7 |
| IMCL post (mmol/kg wet weight) | 3.4±0.6β |
| ΔIMCL (% from baseline) | −22.6±3.3 |
| IHCL pre (%) | 3.6±1.2 |
| IHCL post (%) | 4.0±1.3α |
| ΔIHCL (% from baseline) | +34.9±7.6 |
Values are indicated in mean ± SEM. BMI = body mass index; FFA = free fatty acids; suppression of EGP = suppression of endogenous glucose production = measure of hepatic insulin resistance; M-value = glucose infusion at high insulin dose = measure of peripheral (whole body) insulin resistance; IMCL = intramyocellular lipids; IHCL = intrahepatocellular lipids expressed as % of hepatic water signal; IMCL pre/IHCL pre = before exercise; IMCL post/IHCL post = post exercise; ΔIMCL/ΔIHCL = 2h-aerobic exercise induced changes of IMCL/IHCL; α = p-value <0.002; β = p value <0.001.